• OPEN AN ACCOUNT
Indian Indices
Sensex
81,857.48 319.78
( 0.39%)
Global Indices
Nasdaq
49,444.50 324.78
(0.66%)
Dow Jones
6,973.05 36.44
(0.53%)
Hang Seng
53,322.83 437.58
(0.83%)
Nikkei 225
10,215.77 66.92
(0.66%)
Forex
USD-INR
91.64 0.05
(0.06%)
EUR-INR
108.40 1.13
(1.05%)
GBP-INR
125.02 1.82
(1.48%)
JPY-INR
0.59 0.01
(1.89%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
330.3875196
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
35.49
33728.87
EPS(TTM)
Face Value()
Div & Yield %
76.07
2
1.04
 

mps infotecnics ltd
Tata Investment Corp jumps on bargain hunting
Nov 26,2025
The stock had fallen 6.76% across seven straight sessions. It remains 33.75% below its record high of Rs 1,184 hit on 3 October 2025.

Tata Investment Corporation is a non-banking financial company focused on long-term investments in equity shares and equity-related securities.

In Q2 FY26, consolidated net profit rose 19.78% year-on-year to Rs 148.16 crore, while revenue from operations increased 8.07% to Rs 153.98 crore.

The company also completed its first-ever stock split in October, dividing each Rs 10 face-value share into 10 shares of Re 1 each.